| Filed On | Filing |
|---|---|
| 26 Oct 2026 |
8-K: Other Events
On October 26, 2026, Phathom Pharmaceuticals, Inc. (“Phathom” or the “Company”) announced the U.S. Food and Drug Administration’s (“FDA’s”) establishment of a public docket (Docket No. FDA-2026-N-13038) to solicit comment on legal and re... |
| 23 Oct 2026 |
8-K: Other Events
On October 23, 2026, Phathom Pharmaceuticals, Inc. (“Phathom” or the “Company”) announced that BDR Pharmaceuticals International Pvt. Ltd. (“BDR”) has filed suit against the U.S. Food and Drug Administration (“FDA”) and related Federal D... |
| 29 Sep 2026 |
8-K: Other Events
On September 29, 2026, Phathom Pharmaceuticals, Inc. (“Phathom” or the “Company”) announced the initiation of patient screening in pHalcon-NERD-302, a registrational Phase 3 study evaluating an as-needed (PRN or on-demand) investigationa... |
| 30 Jul 2026 | 8-K: Results of Operations and Financial Condition |
| 23 Jun 2026 | 8-K: Other Events |
| 21 May 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 30 Apr 2026 | 8-K: Results of Operations and Financial Condition |
| 26 Feb 2026 | 8-K: Results of Operations and Financial Condition |
| 08 Jan 2026 | 8-K: Other Events |
| 07 Jan 2026 | 8-K: Results of Operations and Financial Condition |
| 04 Nov 2025 | 8-K: Other Events |
| 30 Oct 2025 | 8-K: Results of Operations and Financial Condition |
| 27 Oct 2025 | 8-K: Other Events |
| 06 Oct 2025 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 07 Aug 2025 | 8-K: Results of Operations and Financial Condition |
| 16 Jun 2025 | 8-K: Other Events |
| 09 Jun 2025 | 8-K: Submission of Matters to a Vote of Security Holders |
| 06 Jun 2025 | 8-K: Regulation FD Disclosure; Other Events |
| 01 May 2025 | 8-K: Results of Operations and Financial Condition |
| 16 Apr 2025 | 8-K: Departure/Election of Directors or Officers; Compensation |
Loading...
